VOYA Investment Management
NAMS icon

VOYA Investment Management’s NewAmsterdam Pharma NAMS Stock Holding History

VOYA Investment Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Hold
27,050
– – ﹤0.01% 1541
2026
Q1 		$866K Sell
27,050
-1,825
-6% -$59.4K ﹤0.01% 1502
2025
Q4 		$1.01M Buy
28,875
+9,575
+50% +$348K ﹤0.01% 1473
2025
Q3 		$549K Buy
+19,300
New +$463K ﹤0.01% 1718

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

VOYA Investment Management's NAMS Position: Q2 2026 in Review

VOYA Investment Management held its NewAmsterdam Pharma (NAMS) position steady in Q2 2026 at 27,050 shares worth $917K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

VOYA Investment Management first reported a position in NAMS in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.01M in Q4 2025. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • VOYA Investment Management held 27,050 shares of NewAmsterdam Pharma worth $917K as of Q2 2026.
  • VOYA Investment Management left its NewAmsterdam Pharma share count unchanged in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1541 holding.
  • VOYA Investment Management first reported a position in NewAmsterdam Pharma in Q3 2025 and has held it in 4 quarters since.
  • VOYA Investment Management's NewAmsterdam Pharma position peaked at $1.01M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.